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Abstract 
To screen antimicrobial activity of Iraqi snake venom, which consist of a diverse range of proteins that 
identified as a potential source of therapeutics. It is unsurprising that snake venoms are being investigated for 
antimicrobial component due to antimicrobial resistance is becoming an increasingly sever issue.  
In this study, antifungal and antibacterial activity were assessed against snake venom by using disc diffusion 
method with different concentrations of venom. The antifungal activity of Iraqi snake crude venom against nine 
different yeasts that isolated from women with vaginal infections (Candida albicans, Candida glabrata,  
Candida tropicalis, Candida krusei, Candida kefyr, Candida parapsilosis, Candida incospicua, Candida 
sphaeriea, and Crypyococcus laurentii), result showed that the crude venom dose not has a noticeable effect on 
all yeasts type, while in antibacterial activity the crude venom result showed the an effect against gram negative 
bacteria, Proteus mirabilis that isolated from patient with urinary tract infection, with inhibition zone about (10 
mm and 8 mm) to (500 µg/ml, 250 µg/ml) of snake venom concentrations respectively.  
It can be conclude that snake venom can be promising therapeutic agents against some microbial infections. 
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1. Introduction 
Antimicrobial peptides  are a small proteins, diverse group that have antimicrobial activity, and their function 
been recognized as important to the animal immune responce, and used as a first line of immune defense by 
many organisms, such as vertebrates, insects, plants, and bacteria [1]. Antimicrobial peptides from natural 
sources have attention in recent times Because of the development of antibiotic resistance in microorganisms, 
and for this reason many antimicrobial peptides have been isolated from different animals, specially snakes 
venoms [2].  
Several studies were done on snake venoms and what contains, the result showed that snake venoms are 
complex mixtures of toxin, enzymes which have different activities on many biological system, and cytotoxins 
antiviral and antibacterial [3, 4].  
 phospholipase A2 and L-amino acid oxidase (LAAO), found in snake venoms had non-toxic and toxic 
antimicrobial activities [5]. Snake venoms are a rich source of bioactive compounds to different 
pharmacological activities because of their complex composition, which  About 90% to 95% weight of the 
venom corresponds to proteins [6, 7]. Enzymatic activity was present in Many proteins isolated from snake 
venoms, such as aminotransferases, colinesterases, catalases, hyaluronidase, ATPases, β-glucosaminidases, 
phosphodiesterases, phospholipases A2, L-amino acid oxidase (LAAO), NAD nucleosidases, serineproteases, 
proteases, and metalloproteinases [7, 8]. Snake venoms and their bioactive derivatives can be promising 
therapeutic agent to some microbial infections and further investigations must be carried out to purification of 
biological active component in snake venom [9], antibacterial potential of Bothrops jararaca venom was great, 
and showing promising results even with resistant bacterial clinical isolates [10]. In this study, we investigated 
the preliminary screening of common Iraqi snake venom to 8 isolates of yeasts, and one isolate of gram negative 
bacteria, similar screening focusing on Antifungal and Antibacterial property have not been attempted 
previously among indigenous Iraqi snakes.  
2. Materials and METHODS 
2.1 Isolations 
All clinical isolates were obtained from patients at Khanaqin General Hospital/ Diyala/ Iraq. 
Clinical isolates obtained as vaginal swaps from women patients with yeasts infection. The vaginal swaps were 
streaked out on sabouraud dextrose agar with added antibiotics [11], and incubated for (24-48) hours at 37°C, to 
obtain adequate growth for the yeast, VITEK Yeast Biochemical Cards were used to identifying the yeasts 
isolated, by using the Vitek-2 compact system instrument, results printed. The yeast species were, (Candida 
albicans, Candida glabrata,  Candida tropicalis, Candida krusei, Candida kefyr, Candida parapsilosis, 
Candida incospicua, Candida sphaeriea, and Crypyococcus laurentii). All isolates stored at 5°C. 
Clinical isolate of Gram negative bacterium obtained from patient with Urinary tract infection (UTI), isolated on 
blood and MacConky agar, after staining by gram stain, the final identification done by Vitek-2 compact system 
by using VITEK G-ve Biochemical Card, result printed, the G-ve bacterium was proteus mirabilis. The 
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bacterium was streaked on to Muller-Hinton agar plates, [12] incubated overnight for growth and stored at 5°C. 
2.2  Snake Venom collection 
Common snake from Iraq-Iran border was caught to obtain the venom. 
A sterile mug with rubber on its nozzle was used to collected the snake venom, by using special stick to catch 
the snake, the snake pushed on the mug nozzle coated with rubber, the venom secreted from snake tusks, the 
venom collected, transfered directly to the laboratory in ice bag, stored at 5°C to prevent proteolysis (Figure. 1). 
 
Figure 1: Showded snake venom collection from common Iraqi snake 
 Thermoscience NanoDrop-2000 instrument (Germany), was used to estimated the venom protein, after the 
device was reset by de ionized water, a drop of venom putted, and the concentration of venom protein was 
(216.074 mg/ml). 
 A serial of snake venom dilution prepared by normal saline with NaCl 0.9 %, as (500 µg/ml, 250 µg/ml, 100 
µg/ml, 50 µg/ml, 25 µg/ml). New solutions were prepared daily [10].  
2.3   Evaluation of Antimicrobial Activity Through Agar Diffusion Method 
• Filter paper was used to make discs, these discs immersed in different concentration of snake venom. 
• Yeasts: yeasts colonies were collected from overnight growth on sabouraud dextrose agar with 
antibiotic, and suspended in 5ml of normal saline NaCl 0.9%, turbidity was adjusted to 0.5 in 
McFarland scale. 10 µl of yeast suspension spread on Mueller Hinton agar containing 2% glucose, and 
0.5 µg/ml methylene blue. Discs were placed on it and incubated for (24-48) hours, as recommended 
by Clinical Laboratory Standards Institute [13]. 
• G-ve bacterium: proteus mirabilis  colonies were collected and suspended in 5ml normal saline (0.9 
NaCl) turbidity was adjusted to 0.5 in McFarland scale [12]. 10 µl of the bacterial suspension spread on 
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Mueller Hinton agar and left standing for 3 min. Diffusion discs saturated with crude snake venom 
solution with five different concentration were added to petri dishes, incubated for 24 hours, [13]. 
• An inhibition zone around the diffusion discs measured in millimeters. Each condition was tested in 
triplicate. 
3. Results and Discussions 
In order to evaluate the antifungal and antibacterial activity of common Iraqi snake venom, we used the discs 
diffusion method with different concentrations of crude venom. 
In Table. 1, Results have showed no antifungal effects against (Candida spp. and Crypyococcus laurentii), as 
shown in (Figure. 2), in contrast, the crude venom was effective against gram negative bacterium proteus 
merabilis: maximum inhibitory zones were 10 mm in 500 µg/ml , and 8 mm in 250 µg/ml, venom concentration 
as shown in (Figure. 3).  
Table 1: Inhibition zone around discs containing different concentration of crude snake venom. Results are 
expressed in mm of diameter (mean of 3 independent experiments). 
Yeasts species 500 µg/ml 250 µg/ml 100 µg/ml 50 µg/ml 25 µg/ml 
Candida albicans - - - - - 
Candida glabrata - - - - - 
Candida tropicalis - - - - - 
Candida krusei - - - - - 
Candida kefyr - - - - - 
Candida parapsilosis - - - - - 
Candida incospicua - - - - - 
Candida sphaeriea - - - - - 
Crypyococcus laurentii - - - - - 
Gram negative bacteria      
Proteus mirabilis 10mm 8mm - - - 
 
Diameter ≥ 8 mm was regarded as susceptible, according to our experience with susceptibility methods due to 
break point was not a available to interpret test results for snake venoms, [14]. The enzymes L-amino oxidase 
(LAAO), and phospholipase A₂ (PLA₂) are common antimicrobial components that have been isolated from 
snake venoms [15], PLA₂ isolated from Agkistrodon halys showed significant inhibition against Proteus 
vulgaris, Proteus mirabilis and Staphylococcus aureus [16]. Other study done on Bungarus fasciatus and 
Ophiophagus hannah which a part from enzymatic proteins, antimicrobial peptides purified from these snake 
venom, showed potent antimicrobial activity against many strains of gram negative bacteria [17, 18]. 
Antimycobacterial activity found in a small peptide vgf-1, that isolated from Naja atra [19]. 
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The ineffectivity of snake venom against yeasts could be due to the yeasts cell wall that composed of (3-glucan, 
i-glucan, manoprotein and a fibrillar layer) [20]. The antimicrobial mechanism of snake venoms under electron 
microscopy showed that the venoms involves cell surface membrane destroy and subsequent cell contents 
leakage [16], which this leakage of cell membrane lead to cell death which still very much unclear. There were 
many factors that effected snake venom antimicrobial mechanism such as net charge of the protein, amino acid 
sequence, salinity of environment, three-dimensional structure and bacterial membrane composition [21]. The 
different proteins and peptides of different snakes venoms can have shown different mechanisms of cell 
membrane disruption that showed differences of susceptibility among the varieties of bacteria, viral, and fungi, 
strains. In other study reported that purified LAAO exhibited significantly higher inhibition than crude venoms 
[22]. In summary this study results showed the activity of snake venom against gram negative bacteria, further 
studies needed to screen the snake venom activity against other type of  gram negative and gram positive 
bacteria and other pathogenic microbe.   
 
Figure 2: Discs diffusion methods showed, there were no effectivity of five different concentration of snake 
crude venom against clinical isolates of yeasts, from women with vaginal yeasts infections,  (Candida albicans, 
Candida glabrata,  Candida tropicalis, Candida krusei, Candida kefyr, Candida parapsilosis, Candida 
incospicua, Candida sphaeriea, and Crypyococcus laurentii). There were no inhibition zone around discs. 
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Figure 3: Discs diffusion methods with five different concentration of crude snake 
venom against proteus mirabilis bacteria, showded: 
1. snake venom 500 µg/ml =10 mm inhibition zone. 
2. snake venom 250 µg/ml = 8 mm inhibition zone. 
3. snake venom 100 µg/ml = 0 no inhibition zone. 
4. snake venom 50 µg/ml    = 0 no inhibition zone. 
5. snake venom 25 µg/ml    = 0 no inhibition zone. 
4. Conclusion  
Snake venom can be promising therapeutic agents against some microbial infections. 
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